Component

Human PDXK Arg220Gln homozygous genotype

Homozygous c.659G>A PDXK genotype in Chelban 2019 Family 2.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Homozygous R220Q cases had PDXK activities of 0.5 and 1.19 pmol per dried-blood-spot punch per hour; controls ranged 2.6-14.7.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_location
    Figure 3F; Results
    experimental_model
    Human families, dried blood spots, recombinant PDXK variants.
    exposure
    Patient blood-spot assay.
    limitations
    Assay-specific values.
    nutrient_topic
    Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B6
    organism
    Homo sapiens
    plain_language
    Inherited activation defects reduced enzyme output.
    primary_references
    [chelban2019] PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. (2019). https://pubmed.ncbi.nlm.nih.gov/31187503/ DOI: 10.1002/ana.25524
    tissue_or_cell_type
    Erythrocytes
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Vitamin B6: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 243–254

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human families, dried blood spots, recombinant PDXK variants. · source_derived_draft · unverified_draft

    ### b6-transport-pdxk-patient-r220q Homozygous R220Q cases had PDXK activities of 0.5 and 1.19 pmol per dried-blood-spot punch per hour; controls ranged 2.6-14.7. Condition category: machinery_impairment nutrient_topic: Vitamin B6 research collection; topical membership is not evidence of a direct dietary effect. plain_language: Inherited activation defects reduced enzyme output. organism: Homo sapiens tissue_or_cell_type: Erythrocytes experimental_model: Human families, dried blood spots, recombinant PDXK variants. limitations: Assay-specific values. exposure: Patient blood-spot assay. evidence_location: Figure 3F; Results [chelban2019] PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. (2019). https://pubmed.ncbi.nlm.nih.gov/31187503/ DOI: 10.1002/ana.25524
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards